Mustafa Suleyman, cofounder of DeepMind and head of DeepMind Health. Photographer: Marlene Awaad/Bloomberg

DeepMind has been given access to mammograms from around 30,000 women that were taken at Jikei University Hospital in Tokyo, Japan, between 2007 and2018

The AI lab, which was acquired by Google for ₤400 million in 2014, wants to see if it’s possible to train an algorithm to spot early signs of breast cancer on these X-rays more effectively than current screening techniques allow. 

The five-year partnership with Jikei University Hospital — described in English and Japanese on DeepMind’s blog on Thursday — builds on an existing partnership that DeepMind announced with the Cancer Research UK Imperial Centre at Imperial College London last November, which gave DeepMind access to mammograms of 7,500 women. 

The company said working with data from partners in multiple countries should help to minimise the chance of bias creeping into its algorithms. AI systems can pick up biases when they’re trained on data that doesn’t represent all the people it’s designed for and DeepMind says it’s a serious problem.

In health, where genetic and biological differences between certain groups are commonplace, this could have a huge impact on patient care,” wrote Dominc King,

clinical lead of DeepMind Health, in the blog. “In the field of mammography, for example, there can be considerable variations in breast density between ethnic groups. Bias in our AI system could therefore result in breast cancers being misidentified or even missed altogether if the technology is not set up to reflect these differences.”

King said that DeepMind Health hopes to work with other international partners in the future.

Professor Ara Darzi, director of the Cancer Research UK Imperial Centre, said in a statement: “The involvement of The Jikei University Hospital in a global research partnership will help take us one step closer to developing technology that could ultimately transform care for the millions of people who develop breast cancer around the world every year.”

DeepMind has several other healthcare projects underway with hospitals across the UK, but not all of them have been well received. DeepMind’s first NHS partnership, a multi-year deal with the Royal Free London NHS Foundation Trust, was deemed to be illegal by the Information Commissioner’s Office, which is the UK data regulator. The arrangement has since been amended to ensure it complies with UK data laws.

The Jikei University Hospital mammograms have been stripped of any information which could be used to identify patients, King said. He added that the mammograms will remain in the full control of the hospital, and stored to world-class standards of security and encryption.

DeepMind has also been given access to de-identified breast ultrasounds from around 30,000 women and 3,500 de-identified breast MRI scans by The Jikei University Hospital.

” readability=”71.5729693293″>
< div _ ngcontent-c15 =" " innerhtml ="

(******** )(********* )Mustafa Suleyman, cofounder of DeepMind and head of DeepMind Health. Professional Photographer: Marlene Awaad/Bloomberg

DeepMind has actually been admitted to mammograms from around 30,000 ladies that were taken at Jikei University Health Center in Tokyo, Japan, in between 2007 and2018

The AI laboratory, which was obtained by Google for ₤400 million in 2014, wishes to see if it’s possible to train an algorithm to identify early indications of breast cancer on these X-rays more successfully than existing screening strategies enable.

The five-year collaboration with Jikei University Healthcare facility– explained in English and Japanese on DeepMind’s blog site on Thursday– constructs on an existing collaboration that DeepMind revealed with the Cancer Research Study UK Imperial Centre at Imperial College London last November, which provided DeepMind access to mammograms of 7,500 ladies.

The business stated dealing with information from partners in several nations must assist to reduce the possibility of predisposition sneaking into its algorithms. AI systems can get predispositions when they’re trained on information that does not represent all individuals it’s developed for and DeepMind states it’s a major issue.

In health, where hereditary and biological distinctions in between specific groups are prevalent, this might have a big effect on client care,” composed Dominc King,

medical lead of DeepMind Health, in the blog site. “ In the field of mammography, for instance, there can be significant variations in breast density in between ethnic groups. Predisposition in our AI system might for that reason lead to breast cancers being misidentified or perhaps missed out on completely if the innovation is not set approximately show these distinctions.”

King stated that DeepMind Health wishes to deal with other global partners in the future.

Teacher Ara Darzi, director of the Cancer Research Study UK Imperial Centre, stated in a declaration: “The participation of The Jikei University Healthcare facility in a worldwide research study collaboration will assist take us one action more detailed to establishing innovation that might eventually change take care of the countless individuals who establish breast cancer worldwide every year.”

DeepMind has a number of other health care jobs underway with medical facilities throughout the UK, however not all of them have actually been well gotten. DeepMind’s very first NHS collaboration, a multi-year handle the Royal Free London NHS Structure Trust, was considered to be unlawful by the Info Commissioner’s Workplace, which is the UK information regulator. The plan has actually because been modified to guarantee it adheres to UK information laws.

The Jikei University Health Center mammograms have been removed of any info which might be utilized to determine clients, King stated. He included that the mammograms will stay in the complete control of the healthcare facility, and kept to first-rate requirements of security and file encryption.

DeepMind has actually likewise been admitted to de-identified breast ultrasounds from around 30,000 ladies and 3,500 de-identified breast MRI scans by The Jikei University Health Center.

” readability =”71
5729693293″ >

.

.

Mustafa Suleyman, cofounder of DeepMind and head of DeepMind Health. Professional Photographer: Marlene Awaad/Bloomberg

.

.

DeepMind has actually been admitted to mammograms from around 30, 000 ladies that were taken at Jikei University Health Center in Tokyo, Japan, in between 2007 and2018

The AI laboratory, which was obtained by Google for ₤ 400 million in 2014, wishes to see if it’s possible to train an algorithm to identify early indications of breast cancer on these X-rays more successfully than existing screening strategies enable.

The five-year collaboration with Jikei University Healthcare facility– explained in English and Japanese on DeepMind’s blog site on Thursday– constructs on an existing collaboration that DeepMind revealed with the Cancer Research Study UK Imperial Centre at Imperial College London last November, which provided DeepMind access to mammograms of 7, 500 ladies.

The business stated dealing with information from partners in several nations must assist to reduce the possibility of predisposition sneaking into its algorithms. AI systems can get predispositions when they’re trained on information that does not represent all individuals it’s developed for and DeepMind states it’s a major issue.

In health, where hereditary and biological distinctions in between specific groups are prevalent, this might have a big effect on client care,” composed Dominc King,

medical lead of DeepMind Health, in the blog site.” In the field of mammography, for instance, there can be significant variations in breast density in between ethnic groups. Predisposition in our AI system might for that reason lead to breast cancers being misidentified or perhaps missed out on completely if the innovation is not set approximately show these distinctions.”

King stated that DeepMind Health wishes to deal with other global partners in the future.

Teacher Ara Darzi, director of the Cancer Research Study UK Imperial Centre, stated in a declaration: “The participation of The Jikei University Healthcare facility in a worldwide research study collaboration will assist take us one action more detailed to establishing innovation that might eventually change take care of the countless individuals who establish breast cancer worldwide every year.”

DeepMind has a number of other health care jobs underway with medical facilities throughout the UK, however not all of them have actually been well gotten. DeepMind’s very first NHS collaboration, a multi-year handle the Royal Free London NHS Structure Trust, was considered to be unlawful by the Info Commissioner’s Workplace, which is the UK information regulator. The plan has actually because been modified to guarantee it adheres to UK information laws.

The Jikei University Health Center mammograms have been removed of any info which might be utilized to determine clients, King stated. He included that the mammograms will stay in the complete control of the healthcare facility, and kept to first-rate requirements of security and file encryption.

DeepMind has actually likewise been admitted to de-identified breast ultrasounds from around 30, 000 ladies and 3, 500 de-identified breast MRI scans by The Jikei University Health Center.

.